Literature DB >> 32342788

Key Expert Stakeholder Perceptions of the Law of Genomics: Identified Problems and Potential Solutions.

Fook Yee Cheung1, Lauren Clatch1, Susan M Wolf1, Ellen Wright Clayton1, Frances Lawrenz1.   

Abstract

The law applicable to genomics in the United States is currently in transition and under debate. The rapid evolution of the science, burgeoning clinical research, and growing clinical application pose serious challenges for federal and state law. Although there has been some empirical work in this area, this is the first paper to survey and interview key scientific and legal stakeholders in the field of genomics to help ground identification of the most important legal problems that must be solved to successfully integrate genomics into clinical care. The respondents in this study identified a wide range of interconnected issues, focusing specifically on the need for clear guidelines about how to use these data, fear of liability for those who use these data, and the need to protect patients from use of this information particularly by insurers, while endorsing data sharing. Developing legal strategies to support appropriate use of genomics now and in the future clearly will require making trade-offs, taking into account the full complexity of this legal ecosystem.

Entities:  

Year:  2020        PMID: 32342788      PMCID: PMC7413498          DOI: 10.1177/1073110520916997

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  20 in total

1.  Physician liability: the next big thing for personalized medicine?

Authors:  Gary E Marchant; Doug E Campos-Outcalt; Rachel A Lindor
Journal:  Per Med       Date:  2011-07       Impact factor: 2.512

2.  The First Amendment Right to Speak About the Human Genome.

Authors:  Barbara J Evans
Journal:  Univ Pa J Const Law       Date:  2014-02-01

3.  Informed Consent in Genome-Scale Research: What Do Prospective Participants Think?

Authors:  Susan Brown Trinidad; Stephanie M Fullerton; Julie M Bares; Gail P Jarvik; Eric B Larson; Wylie Burke
Journal:  AJOB Prim Res       Date:  2012-06-19

4.  Genetics specialists' perspectives on disclosure of genomic incidental findings in the clinical setting.

Authors:  Nancy R Downing; Janet K Williams; Sandra Daack-Hirsch; Martha Driessnack; Christian M Simon
Journal:  Patient Educ Couns       Date:  2012-10-12

5.  Public opinion about the importance of privacy in biobank research.

Authors:  David J Kaufman; Juli Murphy-Bollinger; Joan Scott; Kathy L Hudson
Journal:  Am J Hum Genet       Date:  2009-10-29       Impact factor: 11.025

6.  Prospective biorepository participants' perspectives on access to research results.

Authors:  Laura M Beskow; Sondra J Smolek
Journal:  J Empir Res Hum Res Ethics       Date:  2009-09       Impact factor: 1.742

7.  Public expectations for return of results from large-cohort genetic research.

Authors:  Juli Murphy; Joan Scott; David Kaufman; Gail Geller; Lisa LeRoy; Kathy Hudson
Journal:  Am J Bioeth       Date:  2008-11       Impact factor: 11.229

8.  The legal risks of returning results of genomics research.

Authors:  Ellen Wright Clayton; Amy L McGuire
Journal:  Genet Med       Date:  2012-02-09       Impact factor: 8.822

9.  Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.

Authors:  Barbara J Evans
Journal:  Genet Med       Date:  2013-09-12       Impact factor: 8.822

10.  Experiences and attitudes of genome investigators regarding return of individual genetic test results.

Authors:  Rachel B Ramoni; Amy L McGuire; Jill Oliver Robinson; Debra S Morley; Sharon E Plon; Steven Joffe
Journal:  Genet Med       Date:  2013-05-02       Impact factor: 8.822

View more
  1 in total

1.  Integrating Rules for Genomic Research, Clinical Care, Public Health Screening and DTC Testing: Creating Translational Law for Translational Genomics.

Authors:  Susan M Wolf; Pilar N Ossorio; Susan A Berry; Henry T Greely; Amy L McGuire; Michelle A Penny; Sharon F Terry
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.